MFDS
- Status: likely_approved
🇰🇷 M.V.I. Pediatric in South Korea
M.V.I. Pediatric (RETINOL) regulatory status in South Korea.
Marketing authorisation
M.V.I. Pediatric in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is M.V.I. Pediatric approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for M.V.I. Pediatric in South Korea?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.